SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-042312
Filing Date
2024-05-13
Accepted
2024-05-13 16:15:21
Documents
14
Period of Report
2024-05-09
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0205935-8k_aditxt.htm   iXBRL 8-K 28794
2 UNSECURED PROMISSORY NOTE DATED MAY 9, 2024 ea020593501ex10-1_aditxt.htm EX-10.1 12481
  Complete submission text file 0001213900-24-042312.txt   222026

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adtx-20240509.xsd EX-101.SCH 3018
4 XBRL LABEL FILE adtx-20240509_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE adtx-20240509_pre.xml EX-101.PRE 22361
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0205935-8k_aditxt_htm.xml XML 3779
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 24939246
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)